Other studies have identified that high-grade astrocytomas and gliomas expressing both nuclear and cytoplasmic survivin exhibited a poorer survival rate than individuals with tumors expressing only nuclear or cytoplasmic survivin [46]. The gene discussed is BIRC5; the disease is astrocytoma (excluding glioblastoma).